Daily Levitra Improves Inflammation and Testosterone in Men with Diabetes

Nelson Vergel

Founder, ExcelMale.com
Chronic treatment with the phosphodiesterase-5 (PDE-5) inhibitor vardenafil (Levitra, Bayer/GlaxoSmithKline) for 6 months in men with type 2 diabetes is safe, improves both endothelial function and measures of hemodynamic function, and reduces inflammatory markers.
And a novel and unexpected finding of the treatment for erectile dysfunction was an improvement in testosterone serum levels in a subset of hypogonadal diabetic men.
"Importantly, the clinical trial was originated by investigators, not a drug company," Dr Daniele Santi (University of Modena, Italy), lead investigator, told Medscape Medical News. Dr Santi received the European Society of Endocrinology Young Investigator Award for his study, presented here at the European Congress of Endocrinology (ECE) 2015.



Online statistics

Members online
Guests online
Total visitors

Latest posts